Results 321 to 330 of about 2,166,017 (392)
Food allergens and oral immunotherapy as indicators of eosinophilic oesophagitis. [PDF]
Prz GastroenterolKuźmiński A +2 more
europepmc +1 more source
Differences in familiarity with oral immunotherapy among caregivers of White and Black children with food allergy. [PDF]
Ann Allergy Asthma ImmunolBannon M +11 more
europepmc +1 more source
Mechanisms of oral immunotherapy
Clinical & Experimental Allergy, 2021 AbstractFood allergy presents a significant global health concern with up to 10% of the population affected in developed nations and a steadily increasing prevalence. In many cases, particularly with peanut, tree nut and shellfish, food allergy is a lifelong and potentially life‐threatening diagnosis.
Burks, A. Wesley +3 more
openaire +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Opinion in Allergy & Clinical Immunology, 2021
Purpose of review The prevalence of food allergy is increasing on a global scale, and therefore increased attention is being paid to specific food allergy epidemiology and management. There has been a large amount of progress made in the last decade on human trials of wheat oral immunotherapy (WOIT).
Stephanie, Leeds +2 more
openaire +3 more sources
Purpose of review The prevalence of food allergy is increasing on a global scale, and therefore increased attention is being paid to specific food allergy epidemiology and management. There has been a large amount of progress made in the last decade on human trials of wheat oral immunotherapy (WOIT).
Stephanie, Leeds +2 more
openaire +3 more sources
Oral Immunotherapy for Peanut Allergy in Children 1 to Less Than 4 Years of Age.
NEJM Evidence, 2023Oral Immunotherapy for Peanut Allergy in ChildrenThis trial enrolled children 1 to
G. du Toit +7 more
semanticscholar +1 more source
Oral immunotherapy using boiled peanuts for treating peanut allergy: An open‐label, single‐arm trial
Clinical and Experimental Allergy, 2023Peanut allergy affects 1%–3% of children in Western countries. Boiling peanuts has been demonstrated to result in a hypoallergenic product that may provide a safer way of inducing desensitization in peanut‐allergic patients by first inducing tolerance to
L. Grzeskowiak +5 more
semanticscholar +1 more source
Allergy. European Journal of Allergy and Clinical Immunology, 2023
Oral immunotherapy (OIT) is a promising treatment for food allergies. Our aim was to establish the long‐term safety and efficacy of a novel red meat (RM) OIT in galactose‐alpha‐1,3‐galactose (alpha‐gal) allergy in adults.
D. Ünal +7 more
semanticscholar +1 more source
Oral immunotherapy (OIT) is a promising treatment for food allergies. Our aim was to establish the long‐term safety and efficacy of a novel red meat (RM) OIT in galactose‐alpha‐1,3‐galactose (alpha‐gal) allergy in adults.
D. Ünal +7 more
semanticscholar +1 more source
Cashew oral immunotherapy for desensitizing cashew‐pistachio allergy (NUT CRACKER study)
Allergy. European Journal of Allergy and Clinical Immunology, 2022Oral immunotherapy (OIT) is a treatment option for patients with milk, egg, and peanut allergy, but data on the efficacy and safety of cashew OIT are limited.
A. Elizur +9 more
semanticscholar +1 more source
Phase 2, randomized multi oral immunotherapy with omalizumab ‘real life’ study
Allergy. European Journal of Allergy and Clinical Immunology, 2022Oral immunotherapy (OIT) is frequently discontinued due to adverse events (AEs) and current data suggests that lowering OIT doses can minimize severity and frequency of AEs.
S. Sindher +9 more
semanticscholar +1 more source
Oral immunotherapy in pediatrics
Pediatric Allergy and Immunology, 2020AbstractIgE‐mediated food allergy (FA) has been emerging as a public health priority, mainly in children. It represents a heavy burden for the entire society and not only for the patients and their families. There is evidence that in children with persistent FA, at least to cow's milk, hen's egg, and peanut, oral immunotherapy (OIT) may increase the ...
Arasi S., Castagnoli R., Pajno G. B.
openaire +4 more sources